Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics Inks $1.2M Research Agreement with ABG

NEW YORK (GenomeWeb News) — Interleukin Genetics has signed a $1.2 million research agreement with Alticor subsidiary Access Business Group International to search for genetic variations in four main disease areas: osteoporosis, cardiovascular disease, nutrigenomics, and dermagenomics.
Under the terms of the agreement, Interleukin will conduct studies to correlate SNPs with the risk of osteoporosis or cardiovascular disease in Asian populations, and will also conduct additional studies in North American populations to identify genetic factors that influence skin appearance and athletic performance in response to nutritional products.
The company said that around $800,000 of unspent funding from earlier research pacts with Alticor will be credited against the costs of the ABG agreement.
This is the eighth research agreement between Interleukin Genetics and Alticor. Earlier agreements led to the commercialization of a proprietary genetic test for the risk of early heart disease, a nutritional supplement for those testing positive for the heart risk factor, as well as a general nutrition test panel.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.